DHR Health Opens New Location for Phase II Cardiac Rehabilitation & Secondary Prevention

Translate to Spanish or other 102 languages!

Pictured above, Cardiac Rehab patient Lynda Eason and Cindy Livigni, RN during recovery following a heart attack.

Mega Doctor News

- Advertisement -

Edinburg, TX – DHR Health is proud to announce the opening of a new location for its Phase II Cardiac Rehabilitation and Secondary Prevention program. This service plays a crucial role in returning patients to optimal health after a serious cardiac event. The new DHR Health Cardiac Rehabilitation center can be found in the DHR Health Advanced Care Center building located at 2717 Michael Angelo Drive, Suite 101, Edinburg, Texas.

This service aims to reduce the risk of serious complications and prevent secondary cardiac events from occurring in patients recovering from coronary artery bypass surgery, coronary stent placement, heart attack, valve replacement, congestive heart failure and other cardiovascular conditions. Once released from the hospital, participants can begin the program which includes EKG – monitored and supervised exercise, nutritional counseling, psychosocial counseling, lifestyle modification and risk factor management.    

DHR Health is proud to offer a continuum of care program that is part of the DHR Health Heart Institute, the largest most comprehensive cardiology team in the Rio Grande Valley. 

- Advertisement -

For more information about DHR Health Cardiac Rehabilitation, please call (956) 362-6628.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS McAllen Launches Naming Contest for Advanced Surgical Robot

Using advanced robotic technology to assist surgeons in performing complex procedures with enhanced precision, dexterity and control, robotic surgery represents one of the most significant advancements in modern medicine.

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 

STHS Behavioral Marks Suicide Prevention Month with Community Chalk Event

Every 11 minutes, someone in the United States dies by suicide, according to the Centers for Disease Control and Prevention (CDC), making it one of the nation's leading causes of death.
- Advertisement -